JBT Marel Corporation (NYSE:JBTM – Get Free Report) has received an average rating of “Moderate Buy” from the five ratings firms that are covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $174.6667.
Several analysts recently weighed in on JBTM shares. Zacks Research lowered JBT Marel from a “strong-buy” rating to a “hold” rating in a report on Tuesday, April 28th. Oppenheimer began coverage on JBT Marel in a report on Thursday, May 21st. They set an “outperform” rating and a $175.00 target price on the stock. Seaport Research Partners set a $165.00 target price on JBT Marel in a research report on Thursday, May 21st. Weiss Ratings downgraded JBT Marel from a “hold (c+)” rating to a “hold (c)” rating in a report on Friday, June 5th. Finally, Wall Street Zen lowered JBT Marel from a “buy” rating to a “hold” rating in a research report on Sunday, June 21st.
Check Out Our Latest Analysis on JBT Marel
JBT Marel News Summary
- Positive Sentiment: Second-quarter revenue increased 5% year over year to $981 million, while orders reached $1.03 billion, backlog stood at $1.54 billion and book-to-bill was 1.05x. Protein Solutions revenue rose 11% to $467 million. JBT Marel Q2 revenue rises 5 percent to $981 million
- Positive Sentiment: JBT Marel outlined a plan to generate approximately $25 million to $30 million in annual savings by 2028 and target a 20% adjusted EBITDA margin, offering a potential longer-term profitability catalyst. JBT Marel targets 20 percent adjusted EBITDA margin in 2028
- Positive Sentiment: Adjusted EBITDA rose to $168 million, or a 17.1% margin. Year-to-date operating cash flow was $221 million and free cash flow was $179 million, while the company repurchased about 200,000 shares during the quarter.
- Neutral Sentiment: Management maintained its full-year 2026 revenue outlook, with revenue expected at approximately $4.0 billion to $4.1 billion, and reiterated its adjusted EBITDA margin guidance. JBT Marel Q2 2026 earnings call transcript
- Negative Sentiment: Second-quarter adjusted EPS was $1.95, below the $2.02 analyst consensus, even though it improved from $1.49 a year earlier. The earnings and revenue release therefore disappointed investors. JBT Marel Q2 earnings and revenues miss estimates
- Negative Sentiment: Full-year 2026 EPS guidance of $7.85 to $8.35 is close to, but slightly below, the roughly $8.28 analyst expectation at the midpoint. GAAP EPS guidance was reduced to $4.20-$4.70 to reflect a second-quarter impairment charge, adding pressure to the stock.
Institutional Trading of JBT Marel
A number of institutional investors and hedge funds have recently modified their holdings of JBTM. Northwestern Mutual Wealth Management Co. bought a new position in shares of JBT Marel in the 2nd quarter worth about $29,000. EverSource Wealth Advisors LLC bought a new stake in shares of JBT Marel during the 2nd quarter valued at about $28,000. First Trust Advisors LP bought a new stake in shares of JBT Marel during the 2nd quarter valued at about $4,285,000. Amundi acquired a new stake in JBT Marel during the second quarter worth about $974,000. Finally, Gamco Investors INC. ET AL acquired a new stake in JBT Marel during the second quarter worth about $1,173,000. 98.92% of the stock is owned by institutional investors and hedge funds.
JBT Marel Price Performance
JBTM opened at $132.76 on Friday. The company has a market capitalization of $6.91 billion, a P/E ratio of 41.49, a PEG ratio of 1.49 and a beta of 0.94. The company has a 50-day moving average of $134.95 and a 200-day moving average of $139.56. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.61 and a current ratio of 1.01. JBT Marel has a 1-year low of $113.67 and a 1-year high of $170.19.
JBT Marel (NYSE:JBTM – Get Free Report) last issued its quarterly earnings results on Monday, August 3rd. The company reported $1.95 EPS for the quarter, missing the consensus estimate of $2.02 by ($0.07). The company had revenue of $981.00 million for the quarter. JBT Marel had a return on equity of 8.76% and a net margin of 4.89%.JBT Marel has set its FY 2026 guidance at 7.850-8.350 EPS. Equities analysts expect that JBT Marel will post 8.26 EPS for the current fiscal year.
JBT Marel Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 9th. Shareholders of record on Tuesday, May 26th were issued a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend was Tuesday, May 26th. JBT Marel’s payout ratio is currently 12.50%.
JBT Marel Company Profile
JBT Marel Corporation provides technology solutions to food and beverage industry in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers value-added processing that includes chilling, mixing/grinding, injecting, blending, marinating, tumbling, flattening, forming, portioning, coating, cooking, frying, freezing, extracting, pasteurizing, sterilizing, concentrating, high pressure processing, weighing, inspecting, filling, closing, sealing, end of line material handling, and packaging solutions to the food, beverage, and health market.
Featured Stories
- Five stocks we like better than JBT Marel
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Receive News & Ratings for JBT Marel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JBT Marel and related companies with MarketBeat.com's FREE daily email newsletter.
